Institute of Experimental Physiology, National Scientific and Technical Research Council/University of Rosario, Rosario, Argentina.
Hepatology. 2010 Oct;52(4):1465-76. doi: 10.1002/hep.23846.
Estradiol 17β-D-glucuronide (E(2)17G) is an endogenous, cholestatic metabolite that induces endocytic internalization of the canalicular transporters relevant to bile secretion: bile salt export pump (Bsep) and multidrug resistance-associated protein 2 (Mrp2). We assessed whether phosphoinositide 3-kinase (PI3K) is involved in E(2)17G-induced cholestasis. E(2)17G activated PI3K according to an assessment of the phosphorylation of the final PI3K effector, protein kinase B (Akt). When the PI3K inhibitor wortmannin (WM) was preadministered to isolated rat hepatocyte couplets (IRHCs), it partially prevented the reduction induced by E(2)17G in the proportion of IRHCs secreting fluorescent Bsep and Mrp2 substrates (cholyl lysyl fluorescein and glutathione methylfluorescein, respectively). 2-Morpholin-4-yl-8-phenylchromen-4-one, another PI3K inhibitor, and an Akt inhibitor (Calbiochem 124005) showed similar protective effects. IRHC immunostaining and confocal microscopy analysis revealed that endocytic internalization of Bsep and Mrp2 induced by E(2)17G was extensively prevented by WM; this effect was fully blocked by the microtubule-disrupting agent colchicine. The protection of WM was additive to that afforded by the classical protein kinase C (cPKC) inhibitor 5,6,7,13-tetrahydro-13-methyl-5-oxo-12H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-12-propanenitrile (Gö6976); this suggested differential and complementary involvement of the PI3K and cPKC signaling pathways in E(2)17G-induced cholestasis. In isolated perfused rat liver, an intraportal injection of E(2)17G triggered endocytosis of Bsep and Mrp2, and this was accompanied by a sustained decrease in the bile flow and the biliary excretion of the Bsep and Mrp2 substrates [(3)H]taurocholate and glutathione until the end of the perfusion period. Unlike Gö6976, WM did not prevent the initial decay, but it greatly accelerated the recovery to normality of these parameters and the reinsertion of Bsep and Mrp2 into the canalicular membrane in a microtubule-dependent manner.
The PI3K/Akt signaling pathway is involved in the biliary secretory failure induced by E(2)17G through sustained internalization of canalicular transporters endocytosed via cPKC.
雌二醇 17β-D-葡糖苷酸(E(2)17G)是一种内源性胆汁淤积代谢物,可诱导与胆汁分泌相关的胆小管转运蛋白的内吞内化:胆汁盐输出泵(Bsep)和多药耐药相关蛋白 2(Mrp2)。我们评估了磷酸肌醇 3-激酶(PI3K)是否参与 E(2)17G 诱导的胆汁淤积。E(2)17G 通过评估最终 PI3K 效应物蛋白激酶 B(Akt)的磷酸化来激活 PI3K。当 PI3K 抑制剂wortmannin(WM)预先给予分离的大鼠肝细胞偶联物(IRHCs)时,它部分阻止了 E(2)17G 诱导的荧光 Bsep 和 Mrp2 底物(分别为胆酰赖氨酸荧光素和谷胱甘肽甲基荧光素)分泌的减少。另一种 PI3K 抑制剂 2-吗啉-4-基-8-苯基色酮-4-酮和 Akt 抑制剂(Calbiochem 124005)显示出类似的保护作用。IRHC 免疫染色和共聚焦显微镜分析显示,E(2)17G 诱导的 Bsep 和 Mrp2 内吞内化被 WM 广泛阻止;这种作用被微管破坏剂秋水仙碱完全阻断。WM 的保护作用与经典蛋白激酶 C(cPKC)抑制剂 5,6,7,13-四氢-13-甲基-5-氧代-12H-吲哚[2,3-a]吡咯[3,4-c]咔唑-12-丙腈(Gö6976)的保护作用相加;这表明 PI3K 和 cPKC 信号通路在 E(2)17G 诱导的胆汁淤积中具有不同但互补的作用。在分离的灌注大鼠肝脏中,门静脉内注射 E(2)17G 触发了 Bsep 和 Mrp2 的内吞作用,这伴随着胆汁流量和 Bsep 和 Mrp2 底物[3H]牛磺胆酸钠和谷胱甘肽的胆汁排泄持续减少,直到灌注期结束。与 Gö6976 不同,WM 并没有阻止初始衰减,但它大大加速了这些参数的正常恢复以及 Bsep 和 Mrp2 以微管依赖性方式重新插入胆小管膜。
PI3K/Akt 信号通路通过 cPKC 内化的胆小管转运蛋白的持续内化参与了 E(2)17G 诱导的胆汁分泌失败。